|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61K 39/42 | |||
| C07K 16/10 | |||
| C07K 16/46 | |||
| A61K 39/00 |
| (11) | Patento numeris | 3352791 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16778163.2 |
| Europos patento paraiškos padavimo data | 2016-09-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-08-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-10-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/053599 |
| Data | 2016-09-24 |
| (87) | Numeris | WO 2017/053906 |
| Data | 2017-03-30 |
| (30) | Numeris | Data | Šalis |
| 201562232279 P | 2015-09-24 | US |
| (72) |
VIGNEAULT, Francois, US
BRIGGS, Adrian Wrangham, US
GOLDFLESS, Stephen Jacob, US
TIMBERLAKE, Sonia, US
|
| (73) |
AbVitro LLC,
400 Dexter Avenue North, Suite 1200, Seattle, WA 98109,
US
|
| (54) | HIV ANTIBODY COMPOSITIONS AND METHODS OF USE |
| HIV ANTIBODY COMPOSITIONS AND METHODS OF USE |